LLY EPS
Net income divided by diluted shares outstanding — the per-share profit earned each quarter.
EPS
Latest: $7.94 (2026Q2)
| Period | Value |
|---|---|
| 2024Q1 | $2.48 |
| 2024Q2 | $3.28 |
| 2024Q3 | $1.07 |
| 2024Q4 | $4.88 |
| 2025Q1 | $3.06 |
| 2025Q2 | $6.29 |
| 2025Q3 | $6.21 |
| 2025Q4 | $7.39 |
| 2026Q1 | $8.26 |
| 2026Q2 | $7.94 |
Other LLY Charts
More quarter-by-quarter fundamentals for Eli Lilly and Company
1 / 10
Revenue
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Latest EPS: $7.94 (2026Q2); +26.2% YoY.
Across the 10 quarters from 2024Q1 to 2026Q2, EPS ranged from $1.07 in 2024Q3 to $8.26 in 2026Q1.